All Pharma News
Molecular Partners begins acute myeloid leukemia therapy trial

Molecular Partners begins acute myeloid leukemia therapy trial
CLINICAL TRIALS ARENA
17 Jan 2023
Share Share
Molecular Partners Reports Corporate Highlights and H1 2022 financials

Molecular Partners Reports Corporate Highlights and H1 2022 financials
PRESS RELEASE
25 Aug 2022
Share Share
Molecular Partners: Robbins LLP Reminds Investors of Lead Plaintiff Deadline

Molecular Partners: Robbins LLP Reminds Investors of Lead Plaintiff Deadline
GLOBENEWSWIRE
22 Jul 2022
Share Share
Interim Management Statement Q1 2022 Of Molecular Partners

Interim Management Statement Q1 2022 Of Molecular Partners
PRESS RELEASE
12 May 2022
Share Share
Molecular Partners To Participate In Upcoming Healthcare Investor Conferences

Molecular Partners To Participate In Upcoming Healthcare Investor Conferences
PRESS RELEASE
11 May 2022
Share Share
Molecular Partners CEO, Elected President Of The Swiss Biotech Association

Molecular Partners CEO, Elected President Of The Swiss Biotech Association
PRESS RELEASE
03 May 2022
Share Share
Amgen opts to DARP-out after seeing Molecular Partners data

Amgen opts to DARP-out after seeing Molecular Partners data
Annalee Armstrong FIERCEBIOTECH
27 Apr 2022
Share Share
Molecular Partners Provides Update on Ensovibep on Novartis Quarterly Earnings

Molecular Partners Provides Update on Ensovibep on Novartis Quarterly Earnings
PRESS RELEASE
26 Apr 2022
Share Share
Molecular falls as partner Novartis says more data needed ensovibep

Molecular falls as partner Novartis says more data needed ensovibep
SEEKINGALPHA
26 Apr 2022
Share Share
Novartis seeks FDA EUA for Covid-19 antiviral candidate ensovibep

Novartis seeks FDA EUA for Covid-19 antiviral candidate ensovibep
PHARMACEUTICAL-TECHNOLOGY
11 Feb 2022
Share Share